यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamide - prostata neoplasmer - endokrin terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

sandoz - københavn - bosentanmonohydrat - tablett, filmdrasjert - 125 mg

नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

sandoz - københavn - bosentanmonohydrat - tablett, filmdrasjert - 62.5 mg

यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

bayer ag - darolutamide - prostatic neoplasmer, kastrering-resistant - endokrin terapi - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.

यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateronacetat - prostata neoplasmer - endokrin terapi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

theramex ireland limited - linzagolix choline - leiomyomer - hypofysiske og hypotalamiske hormoner og analoger - yselty is indicated for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.

यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

merck europe b.v.  - lutropin alfa - ovulation induction; infertility, female - sex hormoner og modulatorer av genital systemet, - luveris i forbindelse med preparat for follikelstimulerende hormon (fsh) anbefales for stimulering av follikkelutvikling hos kvinner med alvorlig luteiniserende hormon (lh) og fsh-mangel. i kliniske studier, disse pasientene ble definert av en endogen serum lh nivå.

यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

endoceutics s.a. - prasterone - postmenopause menopause~~pos=headcomp - andre kjønnshormoner og modulatorer av genital systemet - intrarosa er indisert for behandling av vulvar og vaginal atrofi hos postmenopausale kvinner som har moderate til alvorlige symptomer.

नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

aurobindo pharma (malta) limited - floriana - bosentanmonohydrat - tablett, filmdrasjert - 125 mg

नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

aurobindo pharma (malta) limited - floriana - bosentanmonohydrat - tablett, filmdrasjert - 62.5 mg